Summary Thirty-five cases of Hodgkin's disease (HD) were analysed for the presence of Epstein-Barr virus (EBV) and human herpesvirus-6 (HHV-6) DNA. EBV genomes were detected in 11/35 cases while none of the cases was positive for HHV-6. Ten of the EBV-positive cases were subsequently analysed using a probe for the terminal region of the virus; the results suggested that the EBV-infected cells were clonally expanded. EBV subtype specific DNA amplification was used to demonstrate that EBV subtype A, and not subtype B was present in the EBV-positive cases. The age distribution of the EBV-positive cases indicated a statistically significant trend for an increase in positivity with increasing age. This is the first indication that EBV is significantly associated with any subset of HD patients.
The aetiology of Hodgkin's disease (HD) is at present unknown. A bimodal age incidence has been described for the disease with a peak occurring in young adults, aged 15-34 years, and a second peak occurring in older persons (MacMahon, 1966) . A more recent study from the UK failed to detect the second age peak although the age incidence varied for the different subtypes of HD . The nodular sclerosing (NS) subtype of HD showed a unimodal curve with a peak between the ages of 15-34 years. In contrast the mixed cellularity (MC) subtype showed an increase in incidence with increasing age, a pattern similar to that seen in other lymphomas. These features suggest that HD is an heterogeneous entity and that different aetiologies may be involved in different age-groups or disease subtypes.
Epidemiological data have indicated that higher social class and small sibship size are associated with an increased risk of HD in younger age groups (Gutensohn, 1982) . These studies support the hypothesis that HD in younger persons may arise as an unusual and late host response to a common infectious agent. Alexander et al. (1989) found evidence of local spatial clustering of young cases of HD, particularly of the nodular sclerosing subtype supporting the hypothesis that case to case transmission of an infectious agent is involved.
Serological studies have identified members of the human herpesvirus family as possible candidate infectious agents. Many studies have shown an association between elevated antibody titres to Epstein-Barr virus (EBV) antigens and HD (Henle & Henle, 1973; Hesse et al., 1977; Evans & Gutensohn, 1984) . Increased antibody levels are present before the diagnosis of disease (Mueller et al., 1989) suggesting that these findings are not solely a consequence of immunosuppressive therapy. In addition there appears to be an increased risk of HD following infectious mononucleosis (Munoz et al., 1978; Bernard et al., 1987) . Although early studies failed to detect EBV genomes in tumour material from HD patients, recently EBV genomes have been detected in 17-41% of cases using Southern hybridisation (Weiss et al., 1987 (Weiss et al., , 1989 Anagnostopoulos et al., 1989; Boiocchi et al., 1989; Staal et al., 1989) .
Evidence linking other human herpesviruses to HD is less strong though recent studies have shown elevated antibody titres to human herpesvirus type-6 (HHV-6) in HD patients (Ablashi et al., 1988; Biberfeld et al., 1988; Clark et al., 1990) .
We have analysed 35 non-selected cases of HD for the presence of EBV and HHV-6 genomes. In those cases found to be positive for EBV DNA the clonality of the EBVinfected cells was assessed. The results were analysed for age and HD-subtype distribution.
Two strains of EBV have been described which differ in their biological properties and can be distinguished immunologically and molecularly on the basis of differences in the EBNA 2 and EBNA 3 genes (Zimber et al., 1986; Sample et al., 1990) . EBV type B which yields transformed cell lines readily than EBV type A in vitro (Rickinson et al., 1987) , has been considered rare in Western populations, though recent data suggest that type B virus may be widely distributed in the West (Sixbey et al., 1989) .
In order to determine whether a particular viral strain is associated with HD, we investigated the type of EBV present in our positive cases.
The analysis of T-cell receptor (TCR) and immunoglobulin (Ig) gene rearrangement has been used to study the clonality and lineage of the putative malignant cells in HD, the Reed Sternberg cells and their mononuclear counterparts (HRS cells). The results of such studies have been conflicting, in particular there has been significant variation in the number of cases in which TCRP chain (TCRJ) gene rearrangement has been detected Griesser et al., 1987; Raghavachar et al., 1988; O'Connor et al., 1987 (Lukes et al., 1986) . HRS were included in a previous analysis of lymphoma material for HHV-6 DNA (Jarrett et al., 1988 (Erikson et al., 1982 (Siminovitch et al., 1985) . The TCRP gene probe was an XhoI-EcoRI fragment of C91P containing constant region sequences only (Gledhill et al., 1990) .
The probe for HHV-6 was pZH14, a 9 kb fragment of the virus which contains sequences that do not hybridise with other known human herpesviruses (Josephs et al., 1986) . Two EBV probes were used, BamH1-W and EcoRI-D (Arrand et al., 1981) . The BamHI-W probe for the internal repeat element contains sequences reiterated 7-12 times in the EBV genome and was used as a sensitive indicator for the presence of EBV. The EcoRI-D terminal fragment probe was used to assess the clonality of EBV positive samples ( Figure 3) .
The results of these experiments were analysed with respect to the histological subtype of HD and the age of the cases. Three age groups of HD patients can be distinguished epidemiologically; the age ranges of these groups are 0-14 years, 15-34 years and 50 years and over (MacMahon, 1966 (Sample et al., 1990) . A common 5' primer, AGGGATGCCTGGACACAAGA, a type A specific 3' primer, TTGTGACAGAGGTGACAAAA, and a type B specific 3' primer, TTGAAGAGTATGTCCTAAGG, were used to amplify products of 249 bp and 300 bp respectively.
Two jg of high molecular weight DNA and 1 gM primers were included in a reaction mixture containing 1.5 mM MgCl2, 50 mM KCI, 10 mM Tris pH 8.2, 200 tm nucleotides and 3 U Tsp type 2 (Cambio). Amplification was performed in a programmable heat block (Perkin Elmer-Cetus instruments). Samples were denatured by heating them from 700 to 95°C over 1 min, cooled to 55°C over 2 min to anneal the primers, heated to 70°in 1 min and incubated at that temperature for 0.5 min.
Reaction products were visualised on ethidium bromidestaining polyacrylamide gels, and hybridised to type-specific oligonucleotide probes: EBV Type A; TCCAGCCACATG TCCCCCCTCTACGCCCGACA, EBV Type B; AACGTCA ACCTGTCCACAACCCTCGCCAGGAG.
Results
The age, sex, histopathological diagnoses and results of molecular analyses for the 35 HD cases are given in Table I .
The cases analysed included 24 cases of NSHD, six cases of MCHD, two cases of lymphocyte predominant HD (LPHD) and one case of lymphocyte depleted HD (LDHD). In two additional cases no consensus was reached as to the correct diagnosis following histological review. Case 3 was referred to us as NSHD but was considered to be classificable as MCHD by one of us (D.H.W.). For case 9, listed in Table I as NSHD, the possibility of sclerosing mediastinal B-cell lymphoma was raised, but NSHD was not excluded as a differential diagnosis. As case 9 was originally referred to us with a diagnosis of NSHD we have included it in the study.
EBV DNA sequences were detected in 11/35 HD samples using the BamHI-W fragment as probe (Figure 1 ). Ten of the 11 samples were subsequently hybridised to the probe for the terminal fragment, EcoRI-D. There was insufficient DNA to analyse sample 27. Hybridisation of this probe to BamHIEcoRI double digested DNA detected an invariant band of 6.5 kb representing the overlapping regions of the BamHI-A and EcoRI-D fragments and a single band of varying size representing the terminal fragment (Figure 2 and 3) . The data show that the EBV-infected cells, in each case, contain EBV episomes with the same number of terminal repeats. This is consistent with the presence of a clonally expanded population of EBV-infected cells (Raab-Traub & Flynn, 1986) .
The ages and histological subtypes of the EBV-positive and negative cases were compared (Figure 4) . HDNS was compared to all other subtypes because of the small numbers of the LDHD and LPHD subtypes analysed. The comparison showed an excess of EBV-positive cases in the 'all other subtypes' compared to the NSHD category, but this did not attain statistical significance. If cases 3 and 9, for which there was not unanimous agreement on classification, are excluded from the analysis P = .08 using a two tailed Fisher's exact test for difference in proportions. If both cases 3 and 9 are considered to be NSHD then P = 0.16. EBV positivity in the three age groups, <35 years, 35-49 years and > 49 years was analysed. In the younger age group, which made up the majority of the cases, only three out of 23 cases were EBV-positive while in the older age group six out of seven cases were EBV-positive. The trend for an increase in the number of EBV-positive cases with increasing age is statistically significant (Armitage test for trend, X 2= 8.56, P<0.01). The two cases aged <15 years who were included in the group aged <35 years were both EBV positive.
In order to study further the significance of these findings we analysed 14 NHL samples from patients over 60 years old for the presence of EBV. EBV DNA sequences were detected in one out of 14 NHL samples (data not shown). Hybridisation to the EBV probe in the positive sample, an high grade NHL, was detected only after prolonged exposure of the autoradiograph and was weak compared to the hybridisation observed in the HD samples. It was not possible to assess the clonality of the EBV infected cells in this sample because of the lower sensitivity of the EcoRI-D probe compared to the BamHI-W probe.
EBV type A was detected in all of the eight EBV-positive cases analysed by DNA amplification using EBV type-specific primers ( Figure 5) 
The differential diagnosis are shown for cases 3 and 9. HRS, Reed-Stemnberg and mononuclear counterpart; BNHL, B-ell NHL; G, germline; R, rearranged; ND, not done; NK, not known; x, rearrangement detected using Igc probe; Kcde, rearrangement detected using xde probe; *, the percentage of cells containing the IgH gene rearrangement as estimated by densitometry; + + +, > 8%; + +, 3-8%; +, < 3%; -, less than one HRS cell per high-power field; t, the results shown are from the analysis of a lymph node biopsy with the histological appearance ofa reactive node (see text). This case was previously described as MCHD (Gledhill et al., 1990 ), but after reviewing the spleen histology NSHD was considered to be a more appropriate diagnosis. (Katz et al., 1989) .
We have analysed 35 cases of HD for the presence of EBV will result in a ladder of and HHV-6 DNA sequences and have correlated the results en in the EBV positive with the age and subtype of the cases, the presence of Ig or TCRP gene rearrangements and the numbers of HRS cells in the biopsies. We detected EBV DNA in 11/35 non-selected cases of HD occurring in the UK. This substantiates previous studies from laboratories in the USA, Germany and Italy showing the presence of EBV in biopsies from 17-41% of patients with HD (Weiss et al., 1987 (Weiss et al., , 1989 Anagnostopoulos et al., 1989; Boiocchi et al., 1989; Staal et al., 1989; Uccini et al., 1989) . The similarity of the findings from a number of groups indicates that EBV DNA is consistently found in a proportion of cases of HD.
In all of the EBV-positive cases that we analysed, using a 4 probe for the viral terminal repeats, the results were consistent with the presence of a clonally expanded population of EBV-infected cells. In previous studies most of the EBV The significance of these observations has been obscured by the lack of a reported association between EBV-positivity and any particular subtype or age group. This is the first --249 bp study to report a statistically significant association between the presence of EBV genomes and a subset of HD patients. positive cases in MCHD than in NSHD, but again the differences were not statistically significant.
The epidemiological evidence suggesting that HD may have an infectious aetiology has been based largely on studies of HD in the younger peak incidence age group (Gutensohn & Cole, 1980) . NSHD is the predominant subtype amongst young adults and Alexander et al. (1989) have reported evidence of clustering of both NSHD and of cases aged < 35 years.
The age and subtype distribution of our EBV-positive cases do not therefore support a role for this virus as a candidate transmissible agent responsible for HD in young adults. The data suggest that EBV may be involved in the pathogenesis of HD in older persons. The results are in keeping with the hypothesis put forward by MacMahon (1966) which suggests that HD is a grouping of at least three entities, which probably have distinct aetiologies and can be distinguished on the basis of age.
In the older cases reactivation of EBV seems more likely than de novo infection. This may be a result of an age related decline in T-cell immunity (Weksler, 1983) . However it is unlikely that we are simply detecting a proliferation of EBVinfected B-cells secondary to an immune deficit associated with age or with the development of lymphoma. Substantial clonal populations of EBV genomes such as those detected in HD biopsies were not detected in NHL samples from old persons. In addition EBV DNA has been detected in HRS cells by in situ hybridisation Uccini et al., 1989; Weiss et al., 1989) and as discussed below, HRS cells do not consistently show features associated with mature B-cells, such as Ig gene rearrangements.
Most cases in which we detected Ig gene rearrangement had >8% HRS cells. We also found a correlation between the number of HRS cells, which were estimated to be present in the biopsies, and the density of the rearranged bands detected by Southern blotting. These data provide some support for the argument that the rearrangements are present in HRS cells. Ig gene rearrangements were not detected in all cases containing high numbers of HRS cells indicating that in some cases the HRS cells have germline Ig genes.
There was no clear evidence for an association between the detection of EBV DNA and detection of Ig gene rearrangement in the HD samples. The probes used in gene rearrangement analysis are able to detect a clonal gene rearrangement in approximately 2% of a cell population when 10 yg of are analysed (data not shown). The EBV BamHl-W probe, by virtue of containing a reiterated sequence, allows detection of an EBV genome present in <0.45% of the cells (unpublished results). The lesser sensitivity of the Ig gene probe could explain our failure to detect Ig gene rearrangement in EBVpositive cases with <3% HRS cells. However in cases 24 and 25, which were EBV-positive, the population of HRS cells was estimated to be 3-8% and greater than 8% respectively, but Ig gene rearrangement was not detected. This raises the possibility that EBV is infecting a cell type other than a mature B-cell. Similar findings have been reported by Weiss et al. (1987) and Herbst et al. (1989) . EBV has been shown to infect and immortalise lymphocytes at varying stages of maturity (Gregory et al., 1987) . Thus in our EBVpositive cases with germline Ig and TCR genes the virus may have infected a cell at an early stage in differentiation, prior to rearrangement of Ig or TCR genes. Anagnostopoulos et al. (1989) found that EBV-positive cases appeared to have an increased frequency of TCRP gene rearrangement. We did not detect any TCRP gene rearrangements in our series of HD cases, consistent with a number of other reports (Sundeen et al., 1987; Raghavachar et al., 1988; O'Connor et al., 1987) . The reasons for this discrepancy are obscure. EBV type A has been considered the prevalent strain in western countries, while EBV type B has been found mainly in central Africa and New Guinea where Burkitt's lymphoma (BL) in endemic (Zimber et al., 1986; Young et al., 1987) . Recently however, Sixbey et al. (1989) demonstrated that EBV type B was also widespread in a healthy population in the USA, and appeared to be more frequently isolated from immunosuppressed individuals. Despite the immunosuppression associated with HD we detected only type A virus in biopsy material.
This study confirms that clonal EBV genomes are present in a proportion of cases of HD and further shows that older cases are most likely to be EBV-positive. Other aetiological agents may be operating in HD occurring in younger persons. Serological studies have implicated HHV-6 as a candidate virus (Clark et al., 1990 ), however we did not detect HHV-6 DNA in any of 47 cases of HD. Our results do not support a direct role for HHV-6 in the pathogenesis of HD. The data provide support for the hypothesis that HD is an heterogeneous group of conditions with distinct aetiologies. Further studies are required to determine whether the classification of HD cases according to their EBV status is useful in the clinical management of HD patients.
